Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | MRX-2843 |
| Trade Name | |
| Synonyms | MRX2843|MRX 2843 |
| Drug Descriptions |
MRX-2843 inhibits MERTK and FLT3, potentially resulting in increased tumor cell apoptosis and enhanced antitumor immune response (PMID: 27158668, PMID: 39322710). |
| DrugClasses | FLT3 Inhibitor 69 MERTK Inhibitor 13 |
| CAS Registry Number | 1429882-07-4 |
| NCIT ID | C151407 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| MRX-2843 | MRX-2843 | 11 | 2 |
| MRX-2843 + Osimertinib | MRX-2843 Osimertinib | 0 | 1 |
| MRX-2843 + Venetoclax | MRX-2843 Venetoclax | 1 | 0 |